Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin Lacombe

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|November 23, 2024
Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective studyKevin Chevalier, Jean-David Bouaziz, Matthieu Groh, et al.
Journal of Internal Medicine|September 23, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter studyRim Bourguiba, Valentin Lacombe, David Beck, et al.
Rheumatology (Oxford, England)|December 24, 2025
Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control studyPaul Cioni, Yann Nguyen, Julien Rohmer, et al.
Joint Bone Spine|September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysisRomain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Leukemia|January 16, 2026
Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndromeLin-Pierre Zhao, Olivier Kosmider, Maël Heiblig, et al.
Rheumatology (Oxford, England)|April 18, 2026
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndromeAlbrecht Betrains, Vincent Jachiet, Yannick Dieudonné, et al.
Journal of the American Academy of Dermatology|November 7, 2022
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, Loula Papageorgiou, Rim Bourguiba, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|November 23, 2024
Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective studyKevin Chevalier, Jean-David Bouaziz, Matthieu Groh, et al.
Journal of Internal Medicine|September 23, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter studyRim Bourguiba, Valentin Lacombe, David Beck, et al.
Rheumatology (Oxford, England)|December 24, 2025
Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control studyPaul Cioni, Yann Nguyen, Julien Rohmer, et al.
Joint Bone Spine|September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysisRomain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Leukemia|January 16, 2026
Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndromeLin-Pierre Zhao, Olivier Kosmider, Maël Heiblig, et al.
Rheumatology (Oxford, England)|April 18, 2026
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndromeAlbrecht Betrains, Vincent Jachiet, Yannick Dieudonné, et al.
Journal of the American Academy of Dermatology|November 7, 2022
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, Loula Papageorgiou, Rim Bourguiba, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 6